Skip to main content
. 2021 Jan 8;12:179. doi: 10.1038/s41467-020-20429-0

Fig. 4. Competing-risk nomogram and the corresponding calibration curve.

Fig. 4

a Competing-risk nomogram incorporating the collagen signature, tumour size, tumour differentiation and lymph node metastasis. b Calibration curve of the competing-risk nomogram in the training cohort. c Calibration curve of the competing-risk nomogram in the validation cohort.